The prevalence of anemia and iron deficiency is more common in breastfed infants than their mothers in Bhaktapur, Nepal

Abstract

Background/Objectives:

Iron deficiency anemia is a widespread public health problem, particularly in low- and middle-income countries. Maternal iron status around and during pregnancy may influence infant iron status. We examined multiple biomarkers to determine the prevalence of iron deficiency and anemia among breastfed infants and explored its relationship with maternal and infant characteristics in Bhaktapur, Nepal.

Subjects/Methods:

In a cross-sectional survey, we randomly selected 500 mother–infant pairs from Bhaktapur municipality. Blood was analyzed for hemoglobin, ferritin, total iron-binding capacity, transferrin receptors and C-reactive protein.

Results:

The altitude-adjusted prevalence of anemia was 49% among infants 2–6-month-old (hemaglobin (Hb) <10.8 g/dl) and 72% among infants 7–12-month-old (Hb <11.3 g/dl). Iron deficiency anemia, defined as anemia and serum ferritin <20 or <12 μg/l, affected 9 and 26% of infants of these same age groups. Twenty percent of mothers had anemia (Hb <12.3 g/dl), but only one-fifth was explained by depletion of iron stores. Significant predictors of infant iron status and anemia were infant age, sex and duration of exclusive breastfeeding and maternal ferritin concentrations.

Conclusions:

Our findings suggest that iron supplementation in pregnancy is likely to have resulted in a low prevalence of postpartum anemia. The higher prevalence of anemia and iron deficiency among breastfed infants compared with their mothers suggests calls for intervention targeting newborns and infants.

Introduction

The World Health Organization (WHO) estimates that globally ~293 million young children and 468 million non-pregnant women suffer from anemia, among which ~50% are estimated to be attributable to iron deficiency (ID).¹ This makes iron one of the most common micronutrient deficiencies in the world. In addition to inadequate intake of iron, infection and blood loss are common causes of ID, and there is growing evidence suggesting that impairment of mucosal absorption of iron may contribute to the high rates of ID in developing countries.² ID impairs physical activity and cognitive performance and may also cause irreversible intergenerational effects when it occurs in women of reproductive age.^{3, 4} ID anemia (IDA) during pregnancy increases the risk of adverse pregnancy and perinatal outcomes including maternal and neonatal deaths, particularly in severe anemia.⁵

Because of limited resources, ID is usually diagnosed based on the estimation of hemoglobin levels despite the gross lack of sensitivity and specificity of this method.^{6, 7} However, there is no feasible and universally accepted single indicator that can diagnose ID precisely. Low plasma ferritin indicates depletion of iron stores, but values between 20 and 100 μg/l are difficult to interpret because of its nature as a positive acute-phase protein.⁸ Transferrin receptor (TfR) is a relatively recent addition to the iron markers and is less affected by inflammation. However, it is not as widely used as ferritin.

Few studies have assessed determinants for poor iron status by using multiple iron parameters and at the same time measured the association between maternal iron status and that of their breastfed infants. The limited knowledge base is drawn primarily from studies conducted before the universal recommendation of iron and folic acid supplementation to pregnant women.⁹ Widespread use of iron and folic acid supplementation during pregnancy and lactation, secular changes in dietary patterns and rapid urbanization have likely changed the contributions of ID to anemia in low- and middle-income countries such as Nepal.¹⁰ In this paper, we aimed to describe prevalence and predictors of anemia and ID in breastfed infants and explore associations between maternal and infant iron status in a periurban Nepali population.

Materials and methods

Study area and population

Bhaktapur municipality is located in the Bhaktapur district in the Kathmandu valley at an altitude of 1400 m above sea level. The population according to census report of 2011 is 81 748 people, and the majority have agriculture as their main occupation. The study site includes a periurban area with a large proportion of low-income inhabitants. Bhaktapur is the one of the most densely populated districts of Nepal, with a population density of 11 058 people per square km. Newars constitute ~90% of the Bhaktapur municipality population.¹¹

Enrollment procedure

The selection criteria and details on field procedures have been described in detail elsewhere.¹² From January 2008 to February 2009, we enrolled 500 lactating women between 15 and 44 years of age and 474 of their infants below 1 year of age from Bhaktapur municipality in Nepal. We used a two-stage cluster sampling procedure whereby 66 neighborhood streets called 'Toles' were randomly selected as the primary sampling unit from a list of 160. We listed all women living in these Toles, and women and infant pairs were again randomly selected from this list.¹³ The inclusion criteria for the study were that both mothers and children had no ongoing infection (clinically assessed), resided in selected clusters, were willing to provide the household information and consented to participate. Because of acute blood loss and many physiological and hormonal changes during delivery that usually last up to 2 months,¹⁴ we enrolled lactating mothers 2 months after delivery. A total of 1101 eligible mother–infant pairs were recorded during the 1 year of longitudinal follow-up, and 582 were approached for enrollment. Of these, 500 mother–child pairs were enrolled in the study and provided a blood sample. All women gave written informed consent before the start of the study. The study had ethical clearance from the institutional review boards at the Institute of Medicine, Kathmandu, Nepal.

Sample size calculations

We assumed a prevalence of anemia of 25% in this population. Four hundred and fifty mothers were required to detect this prevalence with an absolute precision of 4%, that is, with a 95% confidence interval from 21 to 29%. Assuming 10% loss-to-follow-up, we enrolled 500 women and infant pairs.

Laboratory procedures'

Blood samples were collected from one of the cubital veins using micronutrient-free heparinized polypropylene tubes (Eppendorf, Sarstedt, Germany). Hemoglobin was tested on HemoCue immediately after blood collection (HemoCue, Vedbæk, Denmark) with regular calibration of the instrument as instructed by the manufacturer. The samples were then centrifuged (760 g, for 10 min, room temperature), and plasma was allocated onto micronutrient-free polypropylene vials (Eppendorf, Hinz, Germany) and stored at −20 °C in a freezer in the field site laboratory. Every day these samples were transported to the central laboratory in Kathmandu with an ice pack where they were then stored at −70 °C until they were transported on dry ice to Norway where they were temporarily stored at −80°C before analysis at the Laboratory of Clinical Biochemistry, Haukeland University Hospital (Bergen, Norway). The biochemical iron parameters were analyzed on a Modular Analytics System by Roche Diagnostics (Roche Diagnostics GmbH, Mannheim, Germany) with a 5% coefficient of analytical variation for each test. The plasma ferritin was analyzed by an electrochemiluminescence immunoassay, whereas the soluble TfR and transferrin were analyzed by immunoturbidimetry. Total iron-binding capacity (TIBC) was calculated from transferrin concentrations.

Definitions

According to the WHO, anemia among infants between 6 and 12 months of age is defined as hemoglobin <11 g/dl and depleted iron stores if ferritin <12 μg/l.¹⁵ The corresponding cutoffs for non-pregnant women are 12 g/dl and 15 μg/l, respectively. We also present the prevalence of depleted stores by plasma ferritin <30 μg/l, which is often used in a population where infection and inflammation are common.¹ There is no standard cutoff to define anemia among infants <6 months of age; therefore, we used a cutoff of 10.5 g/dl for Hb and 20 μg/l for ferritin derived from a study among Swedish and Honduran infants.¹⁶ Because of lower partial pressure of oxygen at higher altitude, Centers for Disease Control recommends the adjustment of hemoglobin values when interpreting anemia prevalence among people residing altitude above 1000 m of sea level; hence, we added 0.3 g/dl to the standard cutoff values of Hb to adjust for a local altitude of 1400 m.¹⁷

To assess iron-deficient erythropoiesis (IDE), which is a transient stage of cellular iron insufficiency that can occur before the development of anemia, we measured the concentration of soluble TfR.¹⁸ TfR concentrations are less affected by inflammation than ferritin and can thus reflect early stages of ID at the cellular level provided there are no other causes of abnormal erythropoiesis.¹⁹ There is currently no consensus on a single cutoff value of TfR used to define ID, and hence we used thresholds from similar studies.^{20, 21, 22} We used a concentration of TIBC >83 μmol/l, which is the upper limit value of our laboratory, to indicate an alteration in iron status. We defined IDA as the concurrent presence of anemia and low plasma ferritin or a high TfR concentration. Anemia was considered to have other causes when it was accompanied with high ferritin or low TfR concentration.¹⁵ The TfR-F ratio was calculated by dividing TfR with the log transformation of plasma ferritin, and the TfR-F index was calculated by dividing TfR and ferritin concentrations after converting milligrams of TfR to microgram units. Maternal body mass index (BMI) was calculated as kg/m², and BMI <18.5 kg/m² was considered as undernourished. For children, weight for age, length for age and weight for length z-scores were calculated (WAZ, LAZ and WLZ) based on the WHO growth standards.²³

Infants were considered exclusively breastfed when they reportedly had only consumed breast milk from mother (or wet nurse or expressed breast milk) since birth and had not consumed any liquids or semi/solid foods, except medicines.²⁴

Statistical analysis

Differences between subjects with anemia or ID were tested by independent t-tests for continuous variables and a χ² test for the categorical variables. A threshold of P<0.05 was used to indicate statistical significance for all tests. From a list of candidate covariates including age, gender of infant, C-reactive protein (CRP), breastfeeding status, anthropometry and socioeconomic factors, as well as mother's age, BMI and Hb and iron status, we manually selected and run unadjusted regression analysis.²⁵ A forward purposeful stepwise selection process was carried out to identify important predictors for each of the iron-related variables. Only variables that were showing association at P<0.20 were retained in the final regression model. Final predictors for the multiple linear regression for iron status included infant age and sex, the prevalence of exclusive breastfeeding at 3 months of age, whether mother received iron supplements for at least 6 months and maternal ferrritin concentrations. Statistical analysis was performed by using Stata version 10 (StataCorp. 2013. Stata Statistical Software: Release 10.; StataCorp LP, College Station, TX, USA), and analyses were adjusted for the design effect of the cluster approach. The graph describing the relationship between plasma ferritin with age and gender of infant was constructed using generalized additive models in R statistical software (r-project.org).

Results

Baseline characteristics

The mean age of the 474 infants enrolled in this survey was 6.8 months (ranged 2–12 months), and 45% were below 6 months of age (Table 1). Most of the infants had been delivered at a hospital, were fed colostrum and initiated breastfeeding within 1 h of delivery. However, only 18% of infants practiced exclusive breastfeeding for the first 6 months of life, and average introduction of semisolid foods mostly in the form of home-made or local mixed grain porridge (lito) or readymade cerelac was 3 months.

Table 1. Characteristics of infant and mother enrolled in the micronutrient survey in Bhaktapur, Nepal.

Characteristics	Valuesa
Infants (n=474)
Mean age infant (s.d.) (months)	6.8 (2.8)
Mean birth weight (s.d) (g)b	2891 (491)
Newborn with <2500 g of birth weight) (%)	13
Home delivery	10
Initiation of breastfeeding within 1 h (n=487)	80
Colostrum given	92
Exclusive breastfeeding for >3 months of age	42
Exclusive breastfeeding for 6 months of age	18
Underweight infant (<−2 z-score weight for age)	5
Stunted infant (<−2 z-score length for age)	10
Mothers
Mean age mother (s.d., years)	25.8 (4.2)
Mother with <18.5 BMI (kg/m2)	5
Mother with >25 BMI (kg/m2)	17
Mother with two or more parity	59
Mother received large dose of vitamin A in the past 4 months	2
Household information
Living in joint families	51
Family living in only one room	38
Family using tap drinking water	99
Family ownership of land	55
% of illiterate
Mother	19
Father	6
No work or only seasonal agricultural work
Mother	73
Father	7
Family planning
Mother using Depo-Provera (currently)	46
Number of years of previous Depo use, mean (s.d.)c	3.3 (1.8)
Supplementation during the last pregnancy
Mothers with iron supplementation	90
Months of iron supplementation (n=449), mean (s.d.)	4.8 (1.8)
Months of folic acid supplementation (n=115), mean (s.d.)	2.9 (2.2)
Months of calcium supplementation (n=402), mean (s.d.)	4.8 (1.8)

Abbreviation: BMI, body mass index.

^aValues are %, all such cases, unless otherwise specified.

^bAmong 438 newborns where birth weight was recorded.

^cAmong 259 mothers who used Depo-Provera injection before.

Iron supplementation was reported by 90% of women during their last pregnancy, and one-third of them began using it in the first trimester. Although only about a quarter reported taking folic acid supplementation during their pregnancy, most were likely not aware that it was included in their iron supplements, as most preparations in the market combine the two.

Prevalence of anemia and ID

The mean Hb among infants was 10.7 g/dl, and more than two-thirds of infants >6 months of age (72%) were anemic (Hb <11.3 g/dl altitude-adjusted). Among infants <6 months of age, the prevalence of anemia (<10.8 g/dl age- and altitude-adjusted) was 49%. Only two infants had severe anemia (<7.3 g/dl). The mean hemoglobin concentration was 13.1 g/dl, and 20% of the women were found to be anemic using the altitude-specific cutoff value of Hb <12.3 g/dl (Tables 2a and b).

Table 2a. Hb, ferritin, TIBC, TfR and CRP concentrations among healthy infant and lactating mother in Bhaktapur, Nepal.

Indicators	Infant (2–12 months)	Mother (15–44 years)a	Spearman's correlation (P-value)b
Hb, n	474	500
Mean, s.d. (g/dl)	10.7 (1.3)	13.1 (1.3)	0.16 (0.01)
Anemia adjusted for altitudec	69	20
Mild anemia (%)c	34	17
Moderate anemia	35	3
Severe anemia	0.4	0
Ferritin, n	448	500
Mean (s.d.) (μg/l)	54.8 (69.8)	68.8 (45.9)	0.12 (0.01)
Depleted iron storesd	20	5
Iron deficiency anemiad	17	4
TIBC, n	448	500
Mean (s.d.) (μmol/l)	72.6 (12.1)	72.7 (10.7)	0.09 (0.04)
High TIBC >83 μmol/l	18	15
TfR, n	449	500
Mean (s.d.) (mg/l)	6.2 (3.1)	3.4 (1.5)	0.21 (<0.001)
Iron-deficient erythropoeisise	76	16
Iron-deficient erythropoeisis and anemia	20	6
CRP, n	448	500
Mean (s.d.) (mg/l)	4.3 (10.8)	1.8 (6.5)
> 5 mg/l	21	5
Ratio TfR/log ferritin, mean (s.d.)f	2.3 (3.1)	0.95 (0.88)
>2	38	5
TfR/ferritin index, mean (s.d.)f	499 (1142)	110 (289)
>500	22	3

Abbreviations: CRP, C-reactive protein; Hb, hemoglobin; TfR, plasma transferrin receptor; TIBC, total iron-binding capacity.

^aAll values are in %, unless specified otherwise.

^bSpearman's correlation coefficient between mother and their infant iron parameters.

^cThe cutoffs for altitude-adjusted anemia, mild, moderate and severe were <12.3 , 10.3–12.2, 7.3–10.2 and <7.3 g/dl among mothers and <11.3, 9.3–11.2, 7.3–9.2 and <7.3 g/dl among infants.

^dDepleted iron store was defined as ferritin <15 μg/l among mothers and <12 μg/l for infants. Iron deficiency anemia was considered when depleted iron stores were combined with Hb <12.3 g/dl among mothers and <11.3 g/dl among infants.

^eIron-deficient erythropoesis was defined TfR values of >4.4 mg/l.

^fThe TfR-log ferritin ratio was calculated by dividing TfR with the log transformation of plasma ferritin, and the TfR-ferritin index was calculated by dividing TfR and ferritin concentrations in microgram unit.

Table 2b. Prevalence of anemia and iron deficiency according to age-specific cutoff values among healthy infants in Bhaktapur, Nepal.

State	⩽6 months of age	7–12 months of age
1. Anemia (Hb <10.8 g/dl among ⩽6 months and <11.3 g/dl among 7–12 months infants)	49%	72%
2. Iron deficiency (plasma ferritin <20 μg/l among ⩽6 months and <12 μg/l among 7–12 months infants)	17%	30%
3. Iron deficiency (plasma ferritin <30 μg/l)	30%	71%
4. Iron deficiency anemia (anemia and plasma ferritin <30 μg/l)a	16%	54%
5. Iron deficiency anemia (anemia and plasma ferritin <20 μg/l among ⩽6 months and <12 μg/l among  7–12 months infants)b	9%	26%

Abbreviation: Hb, hemoglobin.

^aAmong infants with normal CRP concentrations, IDA was 18% among ⩽ 6 months and 55% among 7–12-month-old infants.

^bAmong infants with normal CRP concentrations, IDA was 18% among ⩽ 6 months and 55% among 7–12-month-old infants.

Interestingly, only 5% of the women and 17% of the infants ⩽6 months in our study were considered to be iron deficient when we assessed plasma ferritin with a cutoff of <15 and <20 μg/l, respectively. About one-third of infants >6 months of age (30%) were iron deficient (plasma ferritin <12 μg/l). When we used a cutoff value of plasma ferritin <30 μg/l, which was often used in the population where infection and inflammation are common, the prevalence of ID was 18%, 30% and 71% among mothers, infants ⩽6 months and infants >6 months of age, respectively. Using combined indicators of hemoglobin and plasma ferritin, the prevalence of IDA was 4% in mothers and 26% among infants >6 months of age. However, enrolling apparently healthy subjects and screened clinically, 5% women and 21% infants had a CRP concentration >5 mg/l, suggesting a possible subclinical acute infection. None of the iron-deficient women were having high CRP concentration (>5 mg/l), but 12% of iron-deficient infants of >6 months of age were having high CRP concentration. After restricting analyses to infants with normal CRP concentration (CRP <5 mg/l), the prevalence of ID and IDA was 19% and 10% among ⩽6 months and 32% and 29% among >6 months, respectively. Slightly more than one-third (36%) of infants ⩽6 months with normal CRP concentrations had plasma ferritin concentrations <30 μg/l, but the prevalence was 76% among >6 months of age. The prevalence of IDA in infants ⩽6 months (ferritin <30 μg/l and Hb <10.8 g/dl) was 16% in the whole group versus 18% in those with normal CRP. Corresponding figures in >6 months (ferritin <30 μg/l and a slightly higher threshold of Hb <11.3 g/dl) were 54% and 55%, respectively.

The mean TIBC concentration was 72.7 and 72.6 μmol/l in mothers and infants, respectively, with increased concentration >83 μmol/l in 15% (n=77) of the women and 18% (n=79) of the infants. Younger women (<25 years of age) were more vulnerable to ID than older women according to analysis of mean TfR concentrations (3.7 versus 3.2 mg/l, P=0.001). Seventy-six percent of infants (n=341) and 16% (n=79) of mothers had IDE based on the cutoff of TfR 4.4 mg/l. The corresponding figures were 14% (n=61) and 2% (n=9), respectively, when we used a cutoff of TfR 8.3 mg/l. Both the ratio of TfR to log ferritin and TfR to ferritin index showed that fewer than 5% of women were iron deficient, which is comparable to the estimates derived using plasma ferritin. The prevalence of ID among infants was 20–76%, depending mainly on which cutoff value was used for ferritin (Tables 2a and b).

Six percent of women had combination of high plasma TfR concentration and anemia, indicating ID at the cellular level. However, 82% of anemic women did not have a low ferritin concentration. Similarly, 63% of anemic women did not have elevated TfR concentrations. Most of the anemic infants had high TfR concentrations (81%) but not low plasma ferritin concentrations (24%).

Regression analysis

Results from the multiple regression analyses (Table 3) showed that each 1-month increase in infant age was associated with a significant decrease in plasma ferritin concentration of 8.2 μg/l (95% confidence interval: −10.1, −6.4). Mean plasma ferritin concentrations were more than threefold higher among young infants (6 or <6 months) compared with the older infants (88.6 μg/l and 26.8 μg/l, P⩽0.0001). Figure 1 depicts the association between plasma ferritin (restricted among infants with CRP value of <5 mg/l) and child age stratified according to gender. Female infants also had significantly higher Hb, ferritin and lower TIBC and TfR concentrations. Age of infants was also positively associated with TIBC and TfR concentrations. Exclusive breastfeeding for 3 months or more was negatively associated with the hemoglobin concentration. Maternal ferritin concentrations were also associated with infant ferritin concentration but not with other iron parameters.

Table 3. Association of age, gender, breastfeeding, infection, antenatal iron supplementation and maternal anemia with iron parameter of healthy infants in Bhaktapur, Nepala.

Variables/iron parameters	Hemoglobin (g/dl), R2=0·09	Ferritin (μg/l), R2=0.26	TIBC (μmol/l), R2=0.09	TfR (mg/l), R2=0.08
Age (in months)	−0.01 (−0.06, 0.05), P=0.9	−8.2 (−10.1,−6.4), P⩽0.0001	0.88 (0.37, 1.5), P=0.001	0.20 (0.05, 0.34), P=0.008
Female	0.43 (0.15, 0.72), P=0.003	14.0 (4.4, 23.6), P=0.004	−4.0 (−6.6, −1.3), P=0.003	−0.82 (−1.6, −0.08), P=0.03
Exclusively breastfeeding for ⩾3 monthsb	−0.32 (−0.61, −0.02), P=0.03	−8.5 (−18.6, 1.6), P=0.09	2.3 (−0.49, 5.0), P=0.1	0.40 (−0.37, 1.2), P=0.3
Prenatal iron supplementation for at least 6 months to mother	0.18 (−0.11, 0.37), P=0.2	4.3 (−5.4, 14.1), P=0.2	−0.20 (2.9, 2.4), P=0.8	−0.38, (−1.1, 0.38), P=0.3
Maternal ferritin concentration (μg/l)		0.12 (0.01, 0.23), P=0.04		−0.01 (−0.01, 0.01), P=0.5
Low birth weight (<2.5 kg of birth weight)	−0.41 (−0.83, −0.02), P=0.06

Abbreviations: CI, confidence interval; TfR, plasma transferrin receptor; TIBC, total iron-binding capacity.

^aValues are β-coefficient (95% CI) obtained from multiple linear regression analyses adjusted for variables listed in the table (total numbers ranged from 315 to 349).

^bExclusively breastfeeding was defined when child had only breast milk since birth (except medicines).

Figure 1.

Association of plasma ferritin concentration and age of infant according to gender in Bhaktapur, Nepal. Only infants with C-reactive protein value <5 mg/l was included (n=448). The graph was made by using generalized additive models in R. The solid curves depict the estimated mean plasma ferritin concentration; the shaded areas represent the 95% CIs.

Discussion

Our findings from a representative sample of healthy infant and mother pairs from a periurban municipality in Nepal showed that anemia is highly prevalent among infants. Maternal iron stores reflected in plasma ferritin concentration offer protection against infant ID. Yet, even in this setting of greater availability of iron-rich foods than in many rural areas, the prevalence of anemia among infants aged 7–12 months is comparable to the most recent DHS survey in which anemia was observed in 73% and 78% among 9–11- and 6–8-month-old infants, respectively.²⁶

Although we did not collect data on dietary intake of infants (except breast milk intake and introduction of solid/semisolid foods), evidence from other studies from Nepal suggests that dietary diversity is low²⁷ and might also be responsible for IDA in this population. In Bhaktapur, animal-source foods are often not fed to young infants because of a general perception that they will be difficult to digest, which is reflected in their high prevalence of cobalamin deficiency.¹² In the last national survey, iron-rich foods (meat, fish, poultry or eggs) were reported only by 13% of infants in the previous 24 h.²⁶ Besides iron and cobalamin, deficiencies of other nutrients such as vitamin A, C, B9, vitamin D and zinc, as well as toxicity of lead, may also cause anemia.^{28, 29} Effective mucosal absorption of iron also may have been impaired by the presence of inhibiting and/or lack of enhancing factors, as well as intestinal pararasites and an unfavorable microbiome.^{2, 30}

In contrast, the prevalence of maternal anemia in our population (20%) was lower compared with the national figure of 35% for non-pregnant women and is consistent with other estimates of the prevalence of anemia in the Kathmandu valley.²⁶ Interestingly, ID explained only 20–25% of the total anemia burden in the women in this study irrespective of the iron parameters used. The Global Burden of Disease project estimated that the major causes of anemia among women in South Asia are ID, sickle cell anemia, thalassemias and malaria.³¹ However, in Bhaktapur, malaria, sickle cell disease and thalassemias are uncommon. More work is needed to identify other possible causes of anemia in this population, including chronic enteropathy, as well as other nutritional deficiencies such as vitamin B12 and folate. High coverage of iron supplementation during the last pregnancy,¹² lactation amenorrhea, use of Depo-Provera family planning injection³² and the local practice of giving and withholding certain foods during the postpartum period may also contribute to the low prevalence of anemia and ID among women in this population.

Concentrations of Hb and CRP were comparable between male and female and younger and older (>6 months) infants. However, the average concentrations of plasma ferritin were more than threefold higher among the young infants (Figure 1) probably due to temporary redistribution of iron from the red blood cells to the iron stores during the first 6 months of life when fetal hemoglobin is replaced by adult hemoglobin.^{16, 33} In addition to this physiological process, the impact of inflammation and infectious diseases on plasma ferritin complicates selection of an adequate cutoff level to estimate the prevalence of ID and IDA. This is evident from the finding that IDA (17%), which did not explain more than 25% of the total prevalence of anemia (69%) in infants (Table 2a), was significantly increased when we used a ferritin cutoff of 30 μg/l (Table 2b). Most likely, an important reason for the discrepancy between prevalence of anemia and IDA is the use of erroneous ferritin cutoffs, which do not relate adequately to true ID. This is particularly relevant for infants in the first months of life where 30 μg/l may be is too low with respect to the enlarged iron stores with median ferritin levels above 80–100 μg/l.³³ On the other hand, despite enrolling clinically healthy children, 21% had increased CRP. Therefore, we cannot rule out that subclinical, mild infection may have biased the true ferritin cutoff limit with the greatest impact in the older infants where the frequency of higher CRP concentration was higher compared with that in the younger. Plasma ferritin is very sensitive to infection and may even in mild virus infection raise 20–60 μg/l above the preclinical baseline.³⁴

The plasma concentration of TfR is increased by ID, but in contrast to ferritin, it is not seriously affected by infection.¹⁹ Among the infants, there is good consistency between IDA diagnosed by combining anemia with either increased TfR (i.e., IDE) or with ferritin <12 μg/l, being 20% and 17%, respectively. As discussed above, a ferritin cutoff of 12 μg/l is obviously too low; thus, the prevalence of IDA is likely to be >17%. This point is strongly supported by the large difference between IDE (76%) and depleted iron stores (20%). Increased TIBC, which is a measure of long-standing reduced iron absorption, was increased in 18% of infants, which corresponded well with our IDA results. Because of lower iron status and faster growth rate, low birth weight infants are susceptible for developing ID,^{35, 36} which is also supported by our data as they had substantially lower Hb concentration compared with normal weight babies. Our finding of better iron status (reflecting higher Hb and ferritin and lower TfR and TIBC) among female infants is also consistent with previous findings.^{37, 38, 39} This is perhaps due to differences in iron requirements and metabolism⁴⁰ or different sized iron stores in early infancy.⁴¹ Our findings of lower Hb and ferritin concentrations among infants who practiced more than 3 months of exclusive breastfeeding are also in accordance with findings from an earlier study⁴² and are a reflection of the low iron content of breast milk,⁴³ but in discordance with others.^{44, 45} We used a cutoff of 3 months for exclusive breastfeeding instead of the standard WHO recommendation of 6 months. This is because about 50% of our enrolled infants were <6 months of age, and early introduction of complementary foods or drinks is common in this population. Caution is required while interpreting these finding as we used a strict definition of exclusive breastfeeding based on any introduction of food/drink since birth and because feeding patterns are constantly changing, particularly among young infants.

ID is considered the main underlying cause of anemia in developing countries. Our study clearly illustrates the well-known problem of using a common, single cutoff limit to get a true estimate of the prevalence of IDA and distinguish it from other causes that include deficiencies in other nutrients, inflammation, hematological abnormalities and parasitic infestation.^{15, 46, 47} Since the finding of an alarmingly high anemia prevalence, particularly among pregnant women and infants in a micronutrient survey conducted in 1998,⁴⁸ the Government of Nepal, in collaboration with different agencies including the WHO, has endorsed several strategies to reduce anemia. The strategy includes the following: daily supplementation with 60 mg elemental iron sulfate for 180 days during pregnancy and the postpartum period irrespective of baseline iron status; single deworming drugs administered during the second trimester of pregnancy; insecticide-treated bed nets in areas where malaria is a common problem;⁴⁹ and delayed cord clamping (after 2–3 min of birth).^{50, 51} Although we lack data on trends, our findings of a relatively low contribution of iron to overall anemia burden among women, high adherence to iron supplementation during pregnancy and the positive association between maternal ferritin with infant plasma ferritin suggest that these strategies have been effective, at least in the periurban area of Bhaktapur. Nevertheless, as shown in our study, combining tests associated with different stages of negative iron balance makes it possible to discriminate between ID, IDE and IDA. This may be a valuable approach to target more precisely subgroups with different need of iron in a population at risk.

Conclusion

The prevalence of ID and anemia among infants was high, particularly among male infants born to mothers with low iron stores. The contribution of ID to the total anemia prevalence, particularly among mothers, was low, suggesting that anemia may have other causes in this community, which require further exploration. The coverage of iron supplementation among pregnant and lactating women in this population was high, and the observation that high maternal plasma ferritin was associated with lower risk of anemia among infants suggests that increased coverage of this program in rural Nepal and other parts of South Asia could help reduce anemia burden.

The authors declare no conflict of interest.